pravastatin has been researched along with Atrial Fibrillation in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Boer, RA; De Jong, AM; Maass, AH; Oberdorf-Maass, SU; Van Gelder, IC; Van Gilst, WH | 1 |
| Cha, TJ; Cho, KI; Heo, JH; Kim, HS; Kim, KL; Kim, SJ; Lee, JW; Lee, SJ; Shim, IK; Zhang, YH | 1 |
| Hong, JM; Lee, JS; Lim, SG; Park, RW; Shin, D; Yoon, D | 1 |
| Komatsu, T; Kunugida, F; Nakamura, M; Orii, M; Ozawa, M; Sato, Y; Tachibana, H | 1 |
| Crow, RS; Davis, BR; Einhorn, PT; Ford, CE; Haywood, LJ; Massie, BM; Williard, A | 1 |
| Arai, H; Ito, F; Miyagi, N; Someya, T; Tamura, K; Ushiyama, T | 1 |
| Buckley, B; Ford, I; Jukema, JW; Macfarlane, PW; Murray, H; Sattar, N; Shepherd, J; Stott, DJ; Westendorp, RG | 1 |
| Komatsu, T; Kunugita, F; Nakamura, M; Ozawa, M; Sato, Y; Tachibana, H | 1 |
| Bang, CN; Gislason, GH; Greve, AM; Køber, L; Torp-Pedersen, C; Wachtell, K | 1 |
| Diener, HC | 1 |
| Grundtvig, M; Gullestad, L; Gundersen, T; Holt, E; Semb, AG; Tveit, A; Vanberg, P | 1 |
| Blazing, M; Cannon, CP; Gersh, B; McLean, DS; Ravid, S; Shui, A | 1 |
3 trial(s) available for pravastatin and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Topics: Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Comorbidity; Doxazosin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Kaplan-Meier Estimate; Myocardial Infarction; Pravastatin; Prognosis; Smoking | 2009 |
Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Drug Administration Schedule; Electric Countershock; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Norway; Pravastatin; Secondary Prevention; Treatment Outcome | 2004 |
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Thrombolytic Therapy; Tirofiban; Tyrosine | 2008 |
9 other study(ies) available for pravastatin and Atrial Fibrillation
| Article | Year |
|---|---|
Cyclical stretch induces structural changes in atrial myocytes.
Topics: Actins; Animals; Animals, Newborn; Anticholesteremic Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Atrial Remodeling; Calcineurin; Cell Death; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Developmental; Growth Differentiation Factor 15; Heart Atria; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; Potassium Channels; Pravastatin; Pressure; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Mechanical | 2013 |
Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.
Topics: Acetylcholine; Action Potentials; Animals; Atrial Fibrillation; Electrophysiological Phenomena; Heart Atria; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Myocytes, Cardiac; Potassium; Pravastatin; Simvastatin | 2014 |
Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study.
Topics: Aged; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Electronic Health Records; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Simvastatin; Software; Tertiary Care Centers; Warfarin | 2016 |
Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Retrospective Studies; Treatment Outcome | 2009 |
Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Disease-Free Survival; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pravastatin; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
The incidence and risk factors for new onset atrial fibrillation in the PROSPER study.
Topics: Age Distribution; Aged; Aged, 80 and over; Atrial Fibrillation; Electrocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Incidence; Male; Pravastatin; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Risk Reduction Behavior | 2011 |
Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin.
Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pyrroles; Retrospective Studies; Secondary Prevention; Tachycardia, Paroxysmal; Time Factors; Treatment Outcome | 2011 |
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Comorbidity; Denmark; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Polypharmacy; Pravastatin; Propensity Score; Proportional Hazards Models; Pyrroles; Registries; Retrospective Studies; Risk Factors; Sex Factors; Simvastatin; Time Factors; Treatment Outcome | 2014 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |